Biodistribution and Radiation Dosimetry of 90Y-Ibritumomab-Tiuxetan Using 89Zr-Ibritumomab-Tiuxetan and Immuno-Pet in Patients with B-Cell Nhl

O. Visser, S.N.F. Rizvi, M.J. Wondergem, A. van Lingen, G.A.M.S. van Dongen, O.S. Hoekstra, J.M. Zijlstra-Baalbergen, P.C. Huijgens, J.M. Lubberink

Research output: Contribution to journalMeeting AbstractOther research output

Original languageUndefined/Unknown
Pages (from-to)1609
Publication statusPublished - 2010

Cite this